RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/34512660http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/34512660http://www.w3.org/2000/01/rdf-schema#comment"CD8+ T cells are major components of adaptive immunity and confer robust protective cellular immunity, which requires adequate T-cell numbers, targeted migration, and efficient T-cell proliferation. Altered CD8+ T-cell homeostasis and impaired proliferation result in dysfunctional immune response to infection or tumorigenesis. However, intrinsic factors controlling CD8+ T-cell homeostasis and immunity remain largely elusive. Here, we demonstrate the prominent role of Brd4 on CD8+ T cell homeostasis and immune response. By upregulating Myc and GLUT1 expression, Brd4 facilitates glucose uptake and energy production in mitochondria, subsequently supporting naïve CD8+ T-cell survival. Besides, Brd4 promotes the trafficking of naïve CD8+ T cells partially through maintaining the expression of homing receptors (CD62L and LFA-1). Furthermore, Brd4 is required for CD8+ T cell response to antigen stimulation, as Brd4 deficiency leads to a severe defect in clonal expansion and terminal differentiation by decreasing glycolysis. Importantly, as JQ1, a pan-BRD inhibitor, severely dampens CD8+ T-cell immune response, its usage as an anti-tumor agent or latency-reversing agent for human immunodeficiency virus type I (HIV-1) should be more cautious. Collectively, our study identifies a previously-unexpected role of Brd4 in the metabolic regulation of CD8+ T cell-mediated immune surveillance and also provides a potential immunomodulation target."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.org/dc/terms/identifier"doi:10.3389/fimmu.2021.728082"xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Chen Y."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"He X."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Li Y."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Liu J."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Ma X."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Liu W."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Pan T."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Song Z."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Qiao Y."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Zhang X."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Zhang Y."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Wang G."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Xu H."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Zhang H."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Wu S."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Yuan Y."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Zhou M."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Xia B."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Huang F."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/author"Peng Z."xsd:string
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/date"2021"xsd:gYear
http://purl.uniprot.org/citations/34512660http://purl.uniprot.org/core/name"Front Immunol"xsd:string